Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Epirubicin hydrochloride |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Idarubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Doxorubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Medicinal product containing anthracycline and acting as antineoplastic agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
1 |
Product containing epirubicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitoxantrone (substance) |
Is a |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Valrubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Aclarubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Product containing mitoxantrone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL infusion concentrate 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL injection concentrate 12.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL injection concentrate 15mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL infusion solution 22.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL infusion solution 45mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitozantrone 2mg/mL infusion concentrate 15mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitoxantrone hydrochloride 2mg/mL infusion concentrate 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitoxantrone hydrochloride 1mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 2mg/mL infusion solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 50mg/25mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 10 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 20 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 100mg/50mL bladder instillation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 80mg/50mL bladder instillation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 2mg/mL infusion solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 2mg/mL infusion solution 200mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 50mg/50mL bladder instillation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 2mg/mL injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin 2mg/mL injection solution 75mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Pirarubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin hydrochloride |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Doxorubicin hydrochloride |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin citrate liposome (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin liposome (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin hydrochloride liposome (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Doxorubicin liposome (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Idarubicin hydrochloride |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin citrate |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Doxorubicin hydrochloride pegylated liposome |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Aclarubicin hydrochloride (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Plicamycin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Dilated cardiomyopathy caused by anthracycline |
Causative agent (attribute) |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
1 |
Anthracycline therapy |
Direct substance |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
1 |